Pfizer asks Health Canada to approve COVID-19 vaccines for children aged 5-11 – National

0

Pfizer has asked Health Canada to approve the first COVID-19 vaccine for children aged five to 11 years old.

As soon as the regulator gives the green light, providers will be able to start offering the COVID-19 shot to kids, though new child-sized doses might need to be procured.

Read more:
‘Parents are asking all the right questions,’ as COVID-19 vaccine for kids awaits approval: expert

The doses are about one-third the size given to adults and teens age 12 and up.

The vaccine was developed in partnership with Germany’s BioNTech and is now marketed under the brand name Comirnaty. It was authorized for people at least 16 years old last December, and for kids between 12 and 15 in May.

Pfizer already submitted clinical trial data for its child-sized dose to Health Canada at the beginning of the month, and made a formal request for approval to the U.S. Food and Drug Administration last week.

Story continues below advertisement

The Pfizer-BioNTech vaccine has also been tested on children as young as six months old. Topline data for children under five years old is expected as soon as the end of the year.

More coming.

View link »





© 2021 The Canadian Press


FOLLOW US ON GOOGLE NEWS

 

Read original article here

Denial of responsibility! Vigour Times is an automatic aggregator of the all world’s media. In each content, the hyperlink to the primary source is specified. All trademarks belong to their rightful owners, all materials to their authors. If you are the owner of the content and do not want us to publish your materials, please contact us by email – [email protected]. The content will be deleted within 24 hours.

Comments
Loading...
Enable Notifications    OK No thanks